<DOC>
	<DOCNO>NCT00423163</DOCNO>
	<brief_summary>To evaluate therapeutic effectiveness voriconazole + micafungin versus voriconazole alone primary therapy invasive aspergillosis .</brief_summary>
	<brief_title>A Study Evaluate Effectiveness Voriconazole + Micafungin Versus Voriconazole Alone Invasive Aspergillosis</brief_title>
	<detailed_description />
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<mesh_term>Micafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Proven , probable possible invasive aspergillosis Patient 2 year age older The patient administer antifungal agent ( voriconazole , itraconazole , posaconazole , caspofungin , micafungin , anidulafungin , amphotericin B , lipid formulation amphotericin B ) &gt; 7 day immediately prior randomization treatment Possible , Probable , Proven invasive aspergillosis patient enrol . The patient treat voriconazole &gt; 7 day immediately prior randomization</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Aspergillosis/blood</keyword>
	<keyword>micafungin</keyword>
	<keyword>voriconazole</keyword>
	<keyword>Aspergillus</keyword>
</DOC>